Lifecore Biomedical, Inc. De (LFCR) Enterprise Value (2010 - 2025)

Lifecore Biomedical's Enterprise Value history runs 16 years deep, the most recent figure standing at -$8.3 million for Q2 2025.

• In Q2 2025, Enterprise Value rose 2.33% year-over-year to -$8.3 million; the TTM figure through May 2025 stood at -$8.3 million (up 2.33% YoY), while the FY2025 annual figure was -$8.3 million, up 2.33% from the prior year.
• Enterprise Value was -$8.3 million for Q2 2025 at Lifecore Biomedical, down from -$5.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$609000.0 in Q4 2021 to a low of -$19.1 million in Q2 2023.
• Historically, Enterprise Value has averaged -$4.9 million across 5 years, with a median of -$2.7 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Enterprise Value surged 75.4% in 2021, then slumped 1826.44% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$609000.0 in 2021, then tumbled by 875.04% to -$5.9 million in 2022, then slumped by 221.51% to -$19.1 million in 2023, then jumped by 50.47% to -$9.5 million in 2024, then advanced by 12.59% to -$8.3 million in 2025.
• The last three Enterprise Value figures came in at -$8.3 million (Q2 2025), -$5.4 million (Q1 2025), and -$9.5 million (Q4 2024), per Business Quant data.